HRP20090652T1 - Postupak proizvodnje 3(r)-(2-hidroksi-2,2-ditien-2-ilacetoksi)-1-(3-fenoksipropil)-1-azoniabiciklo[2.2.2]oktan bromida - Google Patents

Postupak proizvodnje 3(r)-(2-hidroksi-2,2-ditien-2-ilacetoksi)-1-(3-fenoksipropil)-1-azoniabiciklo[2.2.2]oktan bromida Download PDF

Info

Publication number
HRP20090652T1
HRP20090652T1 HR20090652T HRP20090652T HRP20090652T1 HR P20090652 T1 HRP20090652 T1 HR P20090652T1 HR 20090652 T HR20090652 T HR 20090652T HR P20090652 T HRP20090652 T HR P20090652T HR P20090652 T1 HRP20090652 T1 HR P20090652T1
Authority
HR
Croatia
Prior art keywords
dithien
hydroxy
solvent
phenoxypropyl
azabicyclo
Prior art date
Application number
HR20090652T
Other languages
English (en)
Croatian (hr)
Inventor
Busquets Baque Nuria
Pajuelo Lorenzo Francesca
Original Assignee
Almirall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37808353&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090652(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall filed Critical Almirall
Publication of HRP20090652T1 publication Critical patent/HRP20090652T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
HR20090652T 2006-07-21 2009-12-08 Postupak proizvodnje 3(r)-(2-hidroksi-2,2-ditien-2-ilacetoksi)-1-(3-fenoksipropil)-1-azoniabiciklo[2.2.2]oktan bromida HRP20090652T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200601951A ES2298049B1 (es) 2006-07-21 2006-07-21 Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
PCT/EP2007/006278 WO2008009397A1 (en) 2006-07-21 2007-07-16 Process for manufacturing 3(r)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide

Publications (1)

Publication Number Publication Date
HRP20090652T1 true HRP20090652T1 (hr) 2010-01-31

Family

ID=37808353

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090652T HRP20090652T1 (hr) 2006-07-21 2009-12-08 Postupak proizvodnje 3(r)-(2-hidroksi-2,2-ditien-2-ilacetoksi)-1-(3-fenoksipropil)-1-azoniabiciklo[2.2.2]oktan bromida

Country Status (37)

Country Link
US (1) US8044205B2 (de)
EP (1) EP2044067B1 (de)
JP (1) JP5279708B2 (de)
KR (1) KR101410198B1 (de)
CN (1) CN101490048B (de)
AR (1) AR061933A1 (de)
AT (1) ATE449096T1 (de)
AU (1) AU2007276395B2 (de)
BR (1) BRPI0711500B1 (de)
CA (1) CA2657679C (de)
CL (1) CL2007002078A1 (de)
CO (1) CO6460740A2 (de)
CY (1) CY1109792T1 (de)
DE (1) DE602007003375D1 (de)
DK (1) DK2044067T3 (de)
EC (1) ECSP099033A (de)
EG (1) EG25727A (de)
ES (2) ES2298049B1 (de)
HK (1) HK1124051A1 (de)
HR (1) HRP20090652T1 (de)
IL (1) IL196324A (de)
ME (1) ME01773B (de)
MX (1) MX2009000573A (de)
MY (1) MY145285A (de)
NO (1) NO20090811L (de)
NZ (1) NZ573170A (de)
PE (1) PE20081307A1 (de)
PL (1) PL2044067T3 (de)
PT (1) PT2044067E (de)
RS (1) RS51264B (de)
RU (1) RU2439070C2 (de)
SI (1) SI2044067T1 (de)
TW (1) TWI363057B (de)
UA (1) UA96453C2 (de)
UY (1) UY30475A1 (de)
WO (1) WO2008009397A1 (de)
ZA (1) ZA200810051B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
CA2608561A1 (en) * 2007-10-29 2009-04-29 Carl Paluszkiewicz Motorcycle wind deflector accessory support
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
EP2666465A1 (de) 2012-05-25 2013-11-27 Almirall, S.A. Neuartige Dosierung und Formulierung
CZ306791B6 (cs) 2013-10-29 2017-07-12 Zentiva, K.S. Průmyslově využitelný způsob přípravy aklidinium bromidu o vysoké čistotě
CN103755698A (zh) * 2014-01-06 2014-04-30 万特制药(海南)有限公司 一锅法制备阿地溴铵的工艺
CN103755699A (zh) * 2014-01-06 2014-04-30 万特制药(海南)有限公司 一种2-羟基-2,2-二噻吩-2-基乙酸-1-氮杂二环[2,2,2]辛-3(r)-基酯制备方法
CZ2014188A3 (cs) 2014-03-26 2015-10-07 Zentiva, K.S. Nové formy aclidinium chloridu a způsob jejich přípravy
CN104478871B (zh) * 2014-12-26 2016-09-07 东华大学 一种胆碱m受体拮抗剂阿地溴铵及其制备方法
PT108370B (pt) * 2015-03-30 2018-10-25 Hovione Farm S A Processo de preparação de brometo de aclidínio
WO2016162878A1 (en) * 2015-04-04 2016-10-13 Harman Finochem Limited An advantageous process for preparing 1-azoniabicyclo[2.2.2]octane,3-[(hydroxydi-2-thienylacetyl)oxy]-1-(3¬phenoxypropyl)-, bromide, (3r)- and its novel crystalline form-i
CZ2015257A3 (cs) 2015-04-16 2016-10-26 Zentiva, K.S. Způsob pro zmenšování velikosti částic bromidu [(3R)-1-(3-fenoxypropyl)chinuklidin-1-ium-3-yl] 2-hydroxy-2,2-bis(2-thienyl)acetátu

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
FR2414044A1 (fr) 1978-01-10 1979-08-03 Pharmindustrie Nouveaux derives d'aza-1 bicyclo(2,2,2) octane, utilisables comme medicaments
FR2539135B1 (fr) 1983-01-11 1986-02-28 Essilor Int Hydrogels de polyurethane et procede de fabrication
GB8334494D0 (en) 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
US4675326A (en) 1985-05-08 1987-06-23 Gabriel Amitai Bisquaternary antidotes
US4843074A (en) 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
GB8923590D0 (en) 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators
US5201308A (en) 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
US5091528A (en) 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
DE4108393A1 (de) 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
DE4239402A1 (de) 1992-11-24 1994-05-26 Bayer Ag Pulverinhalator
EP0747355A4 (de) 1994-02-10 1997-04-09 Yamanouchi Pharma Co Ltd Neue carbamate und diese enthaltende arzneimittel
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
SK284447B6 (sk) 1995-04-14 2005-04-01 Glaxo Wellcome Inc. Merací dávkovací inhalátor
FR2756739B1 (fr) 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
PT1087750E (pt) 1998-06-18 2004-02-27 Boehringer Ingelheim Pharma Formulacoes farmaceuticas para aerossois com duas ou mais substancias activas
EP1102579B1 (de) 1998-08-04 2003-03-19 Jago Research Ag Medizinische aerosolformulierungen
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds
DE19921693A1 (de) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
FR2803378B1 (fr) 1999-12-29 2004-03-19 Valeo Climatisation Echangeur de chaleur a tubes a plusieurs canaux, en particulier pour vehicule automobile
GB0009606D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009583D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009605D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
US20020137764A1 (en) 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US6620438B2 (en) 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
US20020183292A1 (en) 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
WO2002036106A2 (de) 2000-10-31 2002-05-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue arzneimittelkompositionen auf der basis von anticholingergika und corticosteroiden
US20020151541A1 (en) 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US6608054B2 (en) 2001-03-20 2003-08-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and endothelin antagonists
US20030158196A1 (en) 2002-02-16 2003-08-21 Boehringer Ingelheim Pharma Gmbh Co. Kg Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020122773A1 (en) 2000-12-20 2002-09-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and dopamine agonists
US20020193393A1 (en) 2001-03-07 2002-12-19 Michel Pairet Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
DE10056104A1 (de) 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
US20020193392A1 (en) 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
PE20020719A1 (es) 2000-12-22 2002-10-11 Almirall Prodesfarma Ag Derivados de carbamato de quinuclidina como agentes antimuscarinicos m3
JP4295985B2 (ja) 2000-12-28 2009-07-15 ラボラトリオス・アルミラル・ソシエダッド・アノニマ 新規なキヌクリジン誘導体およびそれを含む医薬組成物
US20020179087A1 (en) 2001-02-01 2002-12-05 Karl-Heinz Bozung Pharmaceutical compositions containing an oxitropium salt and a betamimetic
DE10104367A1 (de) 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Betamimetika enthaltende Arzneimittelkompositionen mit geringeren Nebenwirkungen
US20020189610A1 (en) 2001-02-01 2002-12-19 Karl-Heinz Bozung Pharmaceutical compositions containing an ipratropium salt and a betamimetic
DE10104370A1 (de) 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Arzneimittelkompositionen mit geringeren Nebenwirkungen
US20030018019A1 (en) 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10130371A1 (de) 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2206021B1 (es) * 2002-04-16 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de pirrolidinio.
ES2195785B1 (es) 2002-05-16 2005-03-16 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2204295B1 (es) * 2002-07-02 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de quinuclidina-amida.
ES2211315B1 (es) 2002-11-12 2005-10-16 Almirall Prodesfarma, S.A. Nuevos compuestos triciclicos.
ES2211344B1 (es) 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
US20050026948A1 (en) 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050026886A1 (en) 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
RU2361586C2 (ru) 2003-07-29 2009-07-20 Берингер Ингельхайм Интернациональ Гмбх Комбинация из антихолинергического средства и стероида и ее применение для лечения заболеваний дыхательных путей путем ингаляции
US20050026887A1 (en) 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
US20050025718A1 (en) 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
ES2232306B1 (es) 2003-11-10 2006-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2239546B1 (es) * 2004-03-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos esteres de quinuclidina cuaternizados.
ES2257152B1 (es) 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
EP2100598A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
ES2298049A1 (es) 2008-05-01
CA2657679A1 (en) 2008-01-24
CL2007002078A1 (es) 2008-01-25
HK1124051A1 (en) 2009-07-03
WO2008009397A1 (en) 2008-01-24
ECSP099033A (es) 2009-02-27
PT2044067E (pt) 2009-12-21
JP5279708B2 (ja) 2013-09-04
ES2298049B1 (es) 2009-10-20
CA2657679C (en) 2014-10-21
WO2008009397A8 (en) 2009-01-22
UY30475A1 (es) 2008-01-02
MX2009000573A (es) 2009-01-29
RU2009105827A (ru) 2010-08-27
MY145285A (en) 2012-01-13
NO20090811L (no) 2009-02-20
AU2007276395A1 (en) 2008-01-24
KR20090031578A (ko) 2009-03-26
NZ573170A (en) 2010-12-24
RU2439070C2 (ru) 2012-01-10
ATE449096T1 (de) 2009-12-15
JP2009544591A (ja) 2009-12-17
RS51264B (sr) 2010-12-31
AR061933A1 (es) 2008-10-01
CN101490048B (zh) 2011-06-29
EP2044067A1 (de) 2009-04-08
DE602007003375D1 (de) 2009-12-31
ZA200810051B (en) 2009-11-25
IL196324A0 (en) 2009-09-22
IL196324A (en) 2012-12-31
UA96453C2 (uk) 2011-11-10
US20090299042A1 (en) 2009-12-03
US8044205B2 (en) 2011-10-25
TW200821307A (en) 2008-05-16
KR101410198B1 (ko) 2014-06-19
CY1109792T1 (el) 2014-09-10
CN101490048A (zh) 2009-07-22
EG25727A (en) 2012-06-11
BRPI0711500A2 (pt) 2011-11-01
PE20081307A1 (es) 2008-09-17
BRPI0711500B1 (pt) 2014-09-16
ES2336045T3 (es) 2010-04-07
SI2044067T1 (sl) 2010-03-31
AU2007276395B2 (en) 2012-03-08
ME01773B (me) 2010-12-31
TWI363057B (en) 2012-05-01
PL2044067T3 (pl) 2010-04-30
CO6460740A2 (es) 2012-06-15
EP2044067B1 (de) 2009-11-18
DK2044067T3 (da) 2010-02-01

Similar Documents

Publication Publication Date Title
HRP20090652T1 (hr) Postupak proizvodnje 3(r)-(2-hidroksi-2,2-ditien-2-ilacetoksi)-1-(3-fenoksipropil)-1-azoniabiciklo[2.2.2]oktan bromida
CN107213885B (zh) 一种阻止亚甲基蓝向外释放的含亚甲基蓝的二氧化硅包裹颗粒的制备方法
CN102584002A (zh) 一种tft-lcd玻璃用的澄清剂、用途及其使用方法
ATE440607T1 (de) Verfahren zur herstellung von galanthaminhydrobromid
CN115722213A (zh) 一种氨基功能化的MOFs材料及其制备方法和在深度去除污废水中有机磷的应用
CN103551053B (zh) 一种疏水复合膜的制备方法
CN104479774A (zh) 一种煤气化制甲烷的设备及方法
WO2008090819A1 (ja) 二環性プロリン化合物の製造方法
CN101747130B (zh) 一种含氮杂质的焦化苯类产品的精制方法
CN203977752U (zh) 一种用于建筑物外层的治霾系统
CN104069719A (zh) 废气净化装置
CN1782038A (zh) 煤炭气化、电厂或其他工业废气配入氢气联产高清洁燃料工艺
HUE031917T2 (en) Pyrimidooxazocin derivatives as mTOR inhibitors
Celik Cumulative Author Index of Volumes 16–19
GB483706A (en) Improvements in or relating to the purification of fuel gases
CN104923078A (zh) 一种印染废水抗菌反渗透膜阻垢剂
CN105505005A (zh) 一种低成本无扬尘磁性黑板用粉笔
Bartolozzi Complexity and self-organization: data analysis and models
CN105440806A (zh) 一种磁性黑板用无扬尘高填充量粉笔
徐峰 et al. Formation and Regeneration of Protoplasts of Taxol-Producing Endophytic Fungus Fusarium maire
CN105505006A (zh) 一种磁性黑板用绿色健康粉笔
TH123955A (th) การผลิตซับสทิทิวเทด เฟนิลีนแอโรแมทิคไดเอสเทอร์ และองค์ประกอบ
TH2199A3 (th) กรรมวิธีการผลิตน้ำแร่ที่มีการเพิ่มปริมาณแมกนีเซียมไอออน โดยผ่านหินแร่ทัลก์
TH2199C3 (th) กรรมวิธีการผลิตน้ำแร่ที่มีการเพิ่มปริมาณแมกนีเซียมไอออน โดยผ่านหินแร่ทัลก์
CN102683650A (zh) 铅炭蓄电池用负极板的生产工艺